» Articles » PMID: 22836085

Metabolic Regulation of Organelle Homeostasis in Lupus T Cells

Overview
Journal Clin Immunol
Date 2012 Jul 28
PMID 22836085
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal T-cell signaling and activation are characteristic features in systemic lupus erythematosus (SLE). Lupus T cells are shifted toward an over-activated state, important signaling pathways are rewired, and signaling molecules are replaced. Disturbances in metabolic and organelle homeostasis, importantly within the mitochondrial, endosomal, and autophagosomal compartments, underlie the changes in signal transduction. Mitochondrial hyperpolarization, enhanced endosomal recycling, and dysregulated autophagy are hallmarks of pathologic organelle homeostasis in SLE. This review is focused on the metabolic checkpoints of endosomal traffic that control immunological synapse formation and mitophagy and may thus serve as targets for treatment in SLE.

Citing Articles

Intricating connections: the role of ferroptosis in systemic lupus erythematosus.

Zhao G, Li X, Zhang Y, Wang X, Deng L, Xu J Front Immunol. 2025; 16:1534926.

PMID: 39967676 PMC: 11832682. DOI: 10.3389/fimmu.2025.1534926.


Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases.

Lu Y, Wang Y, Ruan T, Wang Y, Ju L, Zhou M Front Immunol. 2025; 16:1536020.

PMID: 39917294 PMC: 11798928. DOI: 10.3389/fimmu.2025.1536020.


Lower circulating mitochondrial DNA and increased mitokines suggest significant mitochondrial dysfunction in systemic lupus erythematosus with renal involvement.

Halfon M, Memon A, Hedelius A, Pascual M, Sundquist K, Ribi C Lupus Sci Med. 2025; 12(1).

PMID: 39900408 PMC: 11795360. DOI: 10.1136/lupus-2024-001368.


Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.

Liu M, Wang S, Liang Y, Fan Y, Wang W Clin Rheumatol. 2024; 43(8):2403-2416.

PMID: 38963465 DOI: 10.1007/s10067-024-07046-8.


Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.

Halfon M, Tankeu A, Ribi C Int J Mol Sci. 2024; 25(11).

PMID: 38892349 PMC: 11173067. DOI: 10.3390/ijms25116162.


References
1.
Fernandez D, Bonilla E, Mirza N, Niland B, Perl A . Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 2006; 54(9):2983-8. PMC: 4034146. DOI: 10.1002/art.22085. View

2.
Teachey D, Greiner R, Seif A, Attiyeh E, Bleesing J, Choi J . Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol. 2009; 145(1):101-6. PMC: 2819393. DOI: 10.1111/j.1365-2141.2009.07595.x. View

3.
Dolff S, Abdulahad W, van Dijk M, Limburg P, Kallenberg C, Bijl M . Urinary T cells in active lupus nephritis show an effector memory phenotype. Ann Rheum Dis. 2010; 69(11):2034-41. DOI: 10.1136/ard.2009.124636. View

4.
Ichinose K, Juang Y, Crispin J, Kis-Toth K, Tsokos G . Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Arthritis Rheum. 2010; 63(2):523-9. PMC: 3030625. DOI: 10.1002/art.30085. View

5.
Powell J, Lerner C, Schwartz R . Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol. 1999; 162(5):2775-84. View